healthcare reform

Assessing the Impact of Regulatory Overreach: The FDA and U.S. Customs on Online Pharmacy Orders

The U.S. government, through agencies like the FDA and CBP, plays a crucial role in ensuring drug safety and regulating the entry of goods into the country. While these agencies aim to protect public health, their extensive regulatory reach often causes delays and increased costs, particularly impacting the availability of affordable medications through online pharmacies. This article examines how overregulation by the FDA and stringent enforcement by CBP can hinder access to essential medications, highlighting the need for streamlined processes and policy reforms to better serve the public interest.

Read more

Health or Wealth? The Cost of Big Pharma’s Influence on U.S. Healthcare Policy

Year after year, the pharmaceutical industry ranks among the top spenders in lobbying efforts in Washington, D.C., pouring hundreds of millions into influencing drug approval processes and pricing. This financial influence secures patents and market exclusivity for new drugs, creating monopolies that keep prices high and limit affordable alternatives. Platforms like Ashvin Medicara offer transparency and education about cost-effective pharmaceuticals. It’s crucial for the public to demand open dialogues and reforms to prioritize accessible and affordable healthcare for all.

Read more